Thieler Law Corp advises investors with losses exceeding $100,000 of the June 3, 2019 lead plaintiff deadline in a class action lawsuit filed against Amyris Inc (NASDAQ: AMRS) (“Amyris” or “the Company”). The suit is pending in the U.S. District Court for the Northern District of California and investors, who purchased Amyris Inc securities between March 15, 2018 and March 19, 2019, have until June 3, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Amyris Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Amyris lacked sufficient resources to accurately account for certain transactions; there was a material weakness in Amyris’ internal controls over financial reporting; Amyris would be unable to timely file its annual report; and as a result of the foregoing, defendants’ positive statements about Amyris’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On November 13, 2018, the Company revealed disappointing financial results for the third quarter of 2018, including revenue of $14.9 million compared to $22.5 million in the prior year period, citing the ''volatility of the Vitamin E market.''

Following this news, NASDAQ: AMRS fell $1.76 per share, or 29.83%, to close at $4.14 per share on November 14, 2018.

On March 19, 2019, the Company revealed that it would be unable to timely file its annual report due to ''significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018.'' Amyris also revealed that it ''is in the process of completing its evaluation of internal control over financial reporting and may have further deficiencies to report.''

Following this news, NASDAQ: AMRS fell $0.78 per share, or 20.10%, to close at $3.10 per share on March 20, 2019.

If you were negatively impacted by your investment in Amyris Inc securities between March 15, 2018 and March 19, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185